Emmaus Life Sciences Granted Patent in India for use of Pharmaceutical-grade L-glutamine in Treating Diverticulosis Oct 09, 2019 7:30am EDT
Emmaus Life Sciences Announces its Common Stock to Begin Trading on OTCQB September 26 Sep 26, 2019 8:00am EDT
Emmaus Life Sciences Reinforces Positive Outcomes of Endari ® Clinical Trials, Including Efficacy Findings That Led to FDA Approval Sep 24, 2019 7:00am EDT
Emmaus Life Sciences Announces Withdrawal of Marketing Authorization Application to European Medicines Agency Sep 19, 2019 4:05pm EDT
Emmaus Life Sciences Huddles Up with SCDAAMI to Host "Sideline Sickle Cell" Community Town Hall in Detroit Sep 18, 2019 7:00am EDT
Emmaus Life Sciences to be Delisted from Nasdaq Stock Market Following Hearing Sep 10, 2019 8:00am EDT
Emmaus Life Sciences Granted European Patent for use of Pharmaceutical-grade L-glutamine in Treating Diverticulosis Sep 03, 2019 8:30am EDT
Emmaus Life Sciences to Host "Sideline Sickle Cell" Community Town Hall with ASAP and FSCDR in South Florida Aug 14, 2019 7:00am EDT
Emmaus Life Sciences Reports Sharply Improved 2019 Second Quarter Financial Results Aug 12, 2019 8:00am EDT
